Roberta Diaz Brinton, PhD, inaugural director of the Center for Innovation in Brain Science at the University of Arizona Health Sciences, received $5.9 million from the National Institute on Aging to study the role of gender in Alzheimer’s disease and develop precision medicine interventions to prevent — and potentially reverse — the course of the disease in both women and men.

The funds will enable the UA Department of Family and Community Medicine’s Mobile Health Program to provide more than 2,300 additional patient visits.

The professor of physiology at the University of Arizona College of Medicine – Tucson was recognized by the HeartMath Institute for her teaching on mind-body balance and research on stress reduction and using equine therapy to promote the healing, enrichment and well-being of others

UA medical students’ research shows tragic impact on young people who abuse opioids.

Age-related macular degeneration (AMD) is the most common cause of blindness in individuals over age 55 in developed nations and more than 10 million people in the United States have AMD, according to the Foundation Fighting Blindness.

UA researchers are studying if the combination of dispensing asthma inhalers (corticosteroids) in the emergency department and supervising their use in elementary schools will increase the medication’s use among children with asthma and decrease emergency department visits.

UA engineers are using a $2.1 million grant to improve scanning technologies for challenging patient populations.

A cardiovascular research team at the University of Arizona Sarver Heart Center investigated in a lab model whether metformin, a common diabetes drug, could be an effective treatment for heart failure with preserved ejection fraction (HFpEF). The researchers found that the drug reduced left ventricular stiffness, thereby improving capacity for exercise. Metformin relaxes the left ventricle by making a heart muscle protein called titin more compliant.

Banner Health nurse navigators at the University of Arizona Cancer Center are paired with patients to guide them through their cancer journeys.

In pontocerebellar hypoplasia type 1b, two key biological structures are blocked from binding to one another — which ultimately stunts critical brain growth.